Ultima Tesamorelin Acetate 5mg — Premium Quality Peptide for Lipodystrophy Management

Optimize your therapeutic regimen with Ultima Tesamorelin Acetate. Specifically formulated for the reduction of excess abdominal fat in HIV-infected patients, this high-purity powder is an essential component for managing lipodystrophy. Our product is manufactured with precision to ensure authenticity and potency for your medical requirements.

Specifications

Description & Usage Instructions

Tesamorelin acetate is a growth hormone-releasing factor (GRF) designed for the reduction of visceral adipose tissue. It is specifically indicated for patients suffering from lipodystrophy—a condition characterized by the accumulation of excess fat around the abdomen, often associated with certain HIV medications.

Reconstitution and Administration:

For professional administration, the 2 mg vial must be reconstituted with 2. 1 mL of the provided diluent. When preparing the solution, roll the vial gently between your hands for approximately 30 seconds. It is vital not to shake the vial, as this can degrade the peptide structure.

The solution must be administered via subcutaneous injection into the abdominal skin. To maintain skin health and efficacy, injection sites should be rotated regularly. Avoid injecting into scar tissue, bruises, or the navel. Always inspect the solution visually before use; it must be clear and colorless, without any visible particulate matter or discoloration.

Important Note: For safety and stability, the reconstituted solution should be administered immediately. Any unused solution should be discarded after use. Do not freeze or refrigerate the reconstituted solution.

FAQ

Is Tesamorelin used for general weight loss?
While effective for reducing abdominal fat in specific clinical contexts like lipodystrophy, Tesamorelin is not a standard weight-loss medication for obesity and should be used for its specific indicated purposes.

How should the product be stored?
The powder form should be stored according to manufacturer guidelines. Once reconstituted, the solution should not be refrigerated or frozen, and it should be used immediately to ensure maximum potency.)

What is the recommended dosage?
The recommended dosage for clinical use is 2 mg injected subcutaneously once a day, as determined by professional medical guidance.

What should I do if the solution looks discolored?
Before administration, always inspect the solution. If the liquid appears discolored or contains particulate matter, it should not be used. The solution must be clear and colorless for safe administration.